Antibiotic | CLABSI | P value | |||||
---|---|---|---|---|---|---|---|
Symptomatic- CoNS | Asymptomatic- CoNS | ||||||
S. epidermidis (n = 10) | S. hemolyticus (n = 6) | S. epidermidis (n = 54) | S. hemolyticus (n = 6) | S. schleiferi (n = 5) | S. lugdunensis (n = 5) | ||
Ampicillin (30 μg) | 2 (20%) | 1 (17%) | 47 (87.3%) * | 6 (100%) | 5 (100%) | 5 (100%) | 0.03* |
Cefoxitin (30 μg) | 2 (20%) | 1 (17%) | 45 (85.7%) ** | 6 (100%) | 5 (100%) | 5 (100%) | 0.02** |
Oxacillin | 2 (20%) | 1 (17%) | 45 (85.7%) *** | 6 (100%) | 5 (100%) | 5 (100%) | 0.03*** |
Ciprofloxacin (5 μg) | 1 (10%) | 1 (17%) | 45 (85.7%) α | 4 (67%) | 5 (100%) | 5 (100%) | 0.03α |
Levofloxacin (5 μg) | 2 (20%) | 1 (17%) | 45 (85.7%) μ | 4 (67%) | 4 (80%) | 5 (100%) | 0.03μ |
Trimethoprim/ sulfamethoxazole (1.25/23.25 μg) | 1 (10%) | 1 (17%) | 42 (79.3%) | 4 (67%) | 5 (100%) | 5 (100%) | 0.03 |
Amikacin (30 μg) | 3 (30) | 1 (17%) | 42 (79.3%) | 4 (67%) | 5 (100%) | 5 (100%) | 0.03 |
Gentamicin (10 μg) | 2 (20) | 1 (17%) | 42 (79.3%) | 4 (67%) | 5 (100%) | 5 (100%) | 0.03 |
Erythromycin (30 μg) | 2 (20) | 1 (17%) | 42 (79.3%) | 4 (67%) | 5 (100%) | 5 (100%) | 0.03 |
Clindamycin (30 μg) | 2 (20) | 1 (17%) | 42 (79.3%) | 4 (67%) | 5 (100%) | 5 (100%) | 0.03 |
vancomycin | 0 | 0 | 0 | 0 | 0 | 0 | – |
Linezolid | 0 | 0 | 0 | 0 | 0 | 0 | – |
Tigecycline | 0 | 0 | 0 | 0 | 0 | 0 | – |